BRIEF-PCI: Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
This trial was designed to examine the efficacy of a brief versus a standard prolonged (18
hours) infusion of eptifibatide in preventing troponin I release following successful
coronary stenting.